コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rast to LCMV infection, where balanced CD4 T helper 1 (Th1) and T follicular helper (Tfh) responses w
4 cal processes leading to the initiation of T helper 1 (TH1) immunity against dietary gluten and celia
5 ally distinct subsets of effector T cells (T helper 1 (TH1), TH2, and TH17) defined by expression of
6 ge of lymphocytes, regulatory T cells, and T-helper 1 and 17 cells, all major T-cell subpopulations s
7 buted predominantly to innate and adaptive T-helper 1 cell (TH1) immune responses, whereas the role o
9 NX3, potentially involved in the increased T-helper 1 cytokine-mediated inflammatory damage in heart.
10 iTreg could also rapidly convert to CD4(+) T helper 1 or T helper 17 cells in an inflammatory environ
17 ceptor 6 (CCR6) is critical for pathogenic T helper 17 (Th17) cell migration to the central nervous s
19 mice, interleukin-17a (IL-17a) produced by T helper 17 (TH17) cells (CD4(+) T helper effector cells i
21 gut, we demonstrate that gingiva-resident T helper 17 (Th17) cells developed via a commensal coloniz
22 ny-stimulating factor (GM-CSF) produced by T helper 17 (Th17) cells plays an essential role in autoim
23 id, that reprograms the differentiation of T helper 17 (TH17) cells towards induced regulatory T (iTr
24 dditionally drive autoimmunity by inducing T helper 17 (TH17) cells, which can also contribute to hyp
27 roduction is associated with activation of T-helper 17 cell and inhibition of regulatory T cell with
28 e, plays pivotal roles in pro-inflammatory T helper 17 cell responses linked to autoimmune and inflam
29 dependent type 3 innate lymphoid cells and T helper 17 cells and increased susceptibility to enteric
36 These findings identify the dendritic cell-T helper 17-macrophage axis as a target for the developmen
37 g predominantly within highly inflammatory T-helper 17/T-cytotoxic 17 and T-follicular helper paradig
40 n; (ii) functioning as regulatory T (Treg)/T helper 2 (Th2)-like cells; (iii) interfering with dendri
41 ent of tolerogenic NKT cells with a marked T helper 2 cell bias that, in turn, regulated the differen
43 dritic cells to promote differentiation of T-helper 2 cells and production of their cytokines (IL4, I
44 nflammation, characterized by expansion of T-helper 2 cells in the colon and lung, and infiltration o
46 characterized by an mTOR/Rictor-dependent T helper 2 pathway that guides interleukin-4-dependent mac
52 pitopes displayed by these alleles and drive helper and cytotoxic T cell responses in patients with P
53 cells (ILCs) represent innate versions of T helper and cytotoxic T cells that differentiate from com
54 imited IL-2 production, whereas T follicular helper and double negative (DN) T cells significantly ex
55 r Langerhans cells at governing T follicular helper and germinal center formation after intradermal i
56 Thus, a common Thpok-LRF node supports both helper and regulatory arms of MHC class II responses.
57 icular T cells are heterogeneous, comprising helper and regulatory subsets, has raised questions rega
59 vironments with variable productivity, where helpers at the nest can buffer reproductive failure in h
60 nds (SaPIs), such as SaPI1, exploit specific helper bacteriophages, like 80alpha, for their high freq
61 viral infection and that this led to biased helper CD4 T cell differentiation as well as impaired an
62 significantly higher frequency of follicular helper CD4 T cells compared with the unvaccinated contro
73 Long noncoding RNAs play a pivotal role in T-helper cell development but little is known about their
75 enic germinal center B-cell and T-follicular helper cell frequencies that collaborate to produce anti
76 the effect of increased STAT1 activity on T helper cell polarization and to investigate the therapeu
77 IL-1 induced IL-22 production from a mixed T helper cell population comprised of Th1, Th17, and Th22
78 ge malaria and interfere with conventional T helper cell responses and follicular T helper (TFH)-B ce
79 interferons, normalized TH1 and follicular T helper cell responses, improved TH17 differentiation, cu
82 n and mucin domain 3, which down-regulates T-helper cell type 1 proinflammatory responses and is asso
85 ubtypes associated with high expression of T-helper cell type 2 cytokines and lack of corticosteroid
87 the most from specific agents that target T-helper cell type 2-mediated inflammation and/or corticos
90 regulatory cells (Treg cells) and effector T helper cells (Th cells), and recently identified innate
91 ay be related to development of T follicular helper cells and antiviral inflammatory sequelae derived
93 lisation assays and circulating follicular T-helper cells and plasmablast cells were measured in seru
95 e upregulation of type 2 anti-inflammatory T helper cells and the suppression of type 1 T helper cell
96 ween the frequency of tonsillar T follicular helper cells and tonsillar Ag-specific Ab-secreting cell
103 that Env engagement of the CD4 receptor on T-helper cells results in anergic effects on T-cell recrui
106 GS did abrogate germinal center T follicular helper cells, and blunted PE-specific germinal center B
108 he IL-23R(-/-)MRL.lpr had fewer T follicular helper cells, B cells, and plasma cells, leading to decr
109 fferences between TPH cells and T follicular helper cells, including altered expression of BCL6 and B
110 te acquisition of the virus because CD4(+) T helper cells, required for an effective immune response,
115 targeting the viral RNA silencing suppressor helper-component proteinase (HCpro), presumably in assoc
116 es alone and in synergy with the signature T helper cytokines of either disease, IL-13 and IL-17.
117 erstanding of the mechanism underlying HBoV1 helper-dependent AAV2 replication may also provide insig
118 s of an oncolytic adenovirus (Onc.Ad) with a helper-dependent Ad (HDAd) that expresses a PD-L1 blocki
119 r hand, adeno-associated virus 2 (AAV2) is a helper-dependent dependoparvovirus, and productive AAV2
120 is results in severe defects in T follicular helper development and TH2 polarization, as seen in a ho
121 critical in regulating and assisting early T helper dichotomy toward Th2 responses, which are detrime
122 tential target for developing antimicrobial "helper" drugs that restore the efficacy of existing anti
123 oduced by T helper 17 (TH17) cells (CD4(+) T helper effector cells involved in multiple inflammatory
124 actor (TF) that directs the acquisition of T-helper effector programs during the development of multi
126 examined, Ag-specific interleukin-4 (IL-4) T-helper enzyme-linked immunosorbent spot (ELISpot) assays
127 may limit competition for cellular and viral helper factors and, hence, creates a biological niche fo
138 assisted algorithms redistribute codons in a helper gene, thereby eliminating regions of homology, wh
142 Accordingly, MR1T cells exhibited distinct T helper-like capacities upon MR1-dependent recognition of
145 roliferation and enhanced the frequency of T-helper/memory and cytotoxic T cells (CTLs) in peripheral
146 and rescues, at least in part, T follicular helper numbers and the abnormal Ab production previously
147 T-helper 17/T-cytotoxic 17 and T-follicular helper paradigms with consequent thymic damage and impai
153 this study, we co-transfected AAV2 and AAV8 helper plasmids at different ratios (3:1, 1:1 and 1:3) t
155 l subsets, including peripheral T follicular helper (pTfh) cells, which provide help to B cells for d
157 g an innate checkpoint to control adaptive T helper responses, which has important implications for t
160 ein, we exhibit that CD26 identifies three T helper subsets with distinct immunological properties in
162 ion and effector function of IL-17-producing helper T (T(H)17) cells during autoimmune responses, inc
163 found that LBNSE-CXCL13 recruited follicular helper T (Tfh) and germinal center (GC) B cells, promote
164 tional analyses included in vitro follicular helper T (TFH) cell differentiation and cTFH/naive B-cel
165 regulated genes characteristic of follicular helper T (TFH) cell lineage, including Bcl6, Tcf7 and Cx
166 s were previously included in the follicular helper T (TFH) cell subset, which consists of cells that
167 Recent work identified PD-1(+) follicular helper T (Tfh) cells as an important cellular compartmen
169 hin secondary lymphoid follicles, follicular helper T (TFH) cells have previously been shown to be hi
172 interactions between B cells and follicular helper T (Tfh) cells occurring in lymphoid germinal cent
177 ocess is known to be regulated by follicular helper T (TfH) cells, the mechanism by which B cells ini
178 bstantially impaired formation of follicular helper T (Tfh) cells, which are essential for humoral im
179 st density of cognate peptides to follicular helper T (Tfh) cells, which provide survival signals to
180 defense requires the specification of CD4(+) helper T (Th) cells into distinct fates, including Th1 c
181 iewed as a type 2-regulated disease, type 17 helper T (Th17) cells are known to be influential in ast
183 wn-regulated pathogenic pro-inflammatory and helper T cell 1 (Th1) responses and up-regulated benefic
184 rmine whether blockade of the interleukin 23-helper T cell 17 (IL-23-TH17) pathway with ustekinumab r
186 itory circuit that stabilizes the follicular helper T cell program at least in part through the contr
189 L-5 circumsporozoite protein (CSP) ratios, a helper T cell type 2 cytokine, correlated with higher od
190 ell (Treg) subset that suppresses follicular helper T cell-mediated B cell responses in the germinal
192 Aberrant population expansion of follicular helper T cells (TFH cells) occurs in patients with lupus
194 p 2 innate lymphoid cells (ILC2s) and type 2 helper T cells (Th2 cells) are the primary source of int
195 interleukin-33 (IL-33), which induces type-2 helper T cells (Th2 cells) at the site of infection to p
197 ed genes, increased the number of follicular helper T cells and plasmablasts in the spleen, and led t
198 g cells) and the inflammatory TH17 subset of helper T cells leads to the development of autoimmune an
199 ry T cells and lymph node-derived follicular helper T cells of patients with CVID compared with those
201 the expression of genes in the TH2 subset of helper T cells to enhancer occupancy by the BATF-IRF4 tr
202 he generation of antigen-specific follicular helper T cells, antigen-specific GC B cells, and high-af
203 ulates differentiation of the TH17 subset of helper T cells, thymic T cell development and lymph-node
204 thogen containment to the differentiation of helper T cells, yet the cues that position cells in this
205 tigen-presenting cells (APC) with sensitized helper T lymphocytes (TC) producing Th2 cytokines may de
206 ting immune activation was assessed based on helper T-cell and regulatory T-cell activation in mice.
207 ondary complications and a skewed follicular helper T-cell differentiation in defined monogenic immun
209 t mRNA level ratio, consistent with a type 2 helper T-cell-type inflammatory response, and subacute f
210 a population of PD-1(hi)CXCR5(-) 'peripheral helper' T (TPH) cells that express factors enabling B-ce
211 specially effective at inducing T follicular helper (Tfh) and LLPC responses to Pfs25 when coupled to
214 nity.Excessive expansion of the T follicular helper (TFH) cell pool is associated with autoimmune dis
217 Cognate interactions between T follicular helper (Tfh) cells and B cells are essential for promoti
218 SE-IL-7 induced higher rates of T follicular helper (Tfh) cells and germinal center (GC) B cells from
219 nAbs led to the hypothesis that T follicular helper (Tfh) cells and germinal centers (GC) play a crit
221 egulatory T cells that suppress T follicular helper (Tfh) cells and the generation of high affinity a
222 Recent evidence suggests that T follicular helper (Tfh) cells are the primary producer of IL-4 in t
223 d ICOS(hi) PD-1(hi) circulating T follicular helper (Tfh) cells decreased after rituximab treatment.
225 egulation of humoral responses: T follicular helper (Tfh) cells support germinal center formation and
226 long-lasting interactions with T follicular helper (Tfh) cells, a process that depends on antigen up
227 required for differentiation of T follicular helper (TFH) cells, but not TH1 effectors, elicited by v
229 ential transcription factor for T follicular helper (TFH) cells, is critical as aberrant TFH cell exp
233 lanced CD4 T helper 1 (Th1) and T follicular helper (Tfh) responses were induced, Ad5 immunization re
234 zation of human Th1, Th2, Th17, T follicular helper (Tfh), Treg, and Tr1 cells has helped to define u
235 nal T helper cell responses and follicular T helper (TFH)-B cell interactions in germinal centers.
236 at plant sterols and stanols can shift the T helper (Th) 1/Th2 balance toward a Th1-type immune respo
241 owever, the precise mechanisms involved in T helper (Th) 2 polarization by dendritic cells (DCs) are
242 nary sarcoidosis is classically defined by T-helper (Th) cell type 1 inflammation (e.g., IFN-gamma pr
245 Upon T cell receptor stimulation, CD4(+) T helper (Th) lymphocytes release extracellular vesicles (
246 ting CD3(+)CD8(+) cytotoxic and CD3(+)CD4(+) helper (Th) T lymphocytes, together with increased Th1,
249 blood iNKT, as well as their switch from a T helper (Th-2; ie IL-4, IL-13) to Th-1 (ie IFN-gamma) cyt
251 T cell receptor activation in naive T cells, helper Th17 T cells and regulatory T cells, and Ca(2+) s
252 f naive T cells towards a pro-inflammatory T helper (TH17) cell state and away from a regulatory T ce
253 suppressing interleukin (IL)-17-producing T helper (Th17) cells are widely reported, the effect of t
254 nnate lymphoid cells (ILC2s) resemble type 2 helper (Th2) cells in cytokine production and contribute
255 crete and permanent functional categories of helpers that resemble the caste systems found in eusocia
257 Immunization with low doses of gp96 primes T helper type 1 (Th1) immune responses, whereas high-dose
259 onders or through conversion of Tregs into T helper type 1 (Th1) or type 17 (Th17) effector lymphocyt
260 riers was stimulated with viable S. aureus T-helper type 1 (Th1), Th2, and Th17 cytokine expression w
261 ll responses, we examined the frequency of T-helper type 1 (Th1)/Tc1, Th2/Tc2, Th9/Tc9, Th17/Tc17, Th
263 onse to infection and in the generation of T-helper type 1 cells, favoring cell-mediated immunity.
264 , inflammatory morphea is characterized by T helper type 1 cytokine imbalance in serum, particularly
266 are responsible for the activation of the T helper type 1 immune response in humans, therefore const
267 lyclonal (ie, they expressed CD4 and CD8), T-helper type 1 polarized, and polyfunctional (ie, they pr
268 Multiplex cytokine analysis confirmed the T helper type 1-polarized response induced by these protei
269 ver, the immune phenotype and functions of T helper type 17 (Th17) cells induced by healthy (PH) vers
270 f immunoinflammatory mediator performance (T-helper Type 17 [Th17]/Th2 and Th1/Th2 cell levels) were
273 ts in defective maintenance of AD-specific T helper type 2 (Th2) and psoriasis-specific Th17 cells in
274 nterleukin (IL)-4 and IL-13, released from T-helper type 2 (Th2) cells, drive macrophage polarization
277 nnate antiviral activity) contributes to a T helper type 2 biased response and predisposes to feature
278 ion of CD4(+) T cells into tumor-promoting T helper type 2 cell (Th2 cell), Th17 cell, and regulatory
279 IL-5, prostaglandin D2, and eosinophil and T-helper type 2 cell chemokines compared with healthy subj
281 T3(mut) patient lymphocytes with increased T helper type 2 cytokine expression and elevated IgE.
283 f eosinophils and mast cells, elevation of T helper type 2 cytokines/chemokines expression, and reduc
284 1 and TLR6 may cause polarization toward a T helper type 2 immune response via the release of IL-25 a
285 thermore, bleomycin-dependent induction of T helper type 2-skewed immune polarization, M2 macrophage
286 h the inhibition of fibroblast activation, T helper type 2-skewed immune polarization, M2 macrophage
287 ced IL-1beta and IL-18 production, lowered T-helper type-1 immune responses, and reduced atherosclero
288 ave elucidated functional roles for CD4(+) T-helper type-2 lymphocytes (TH 2 cells), their associated
289 AAV2 replication requires coinfection with a helper virus (e.g., adenovirus or herpesvirus) or treatm
293 only a host cell for replication but also a helper virus such as an adenovirus or a herpesvirus.
294 2) depends on the simultaneous presence of a helper virus such as herpes simplex virus 1 (HSV-1) for
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。